What types of patent applications require a Sequence Listing XML?
According to MPEP 2415, the Sequence Listing XML requirement applies to “Patent applications that contain disclosures of nucleotide and/or amino acid sequences.” This means any patent application filed on or after July 1, 2022, that includes biological sequence data as defined in 37 CFR 1.831(b) must submit this data in the Sequence Listing XML format…
Read MoreHow should biological sequence listings be submitted in patent applications?
The submission requirements for biological sequence listings in patent applications depend on the filing date of the application: For applications filed before July 1, 2022: Submit a “Sequence Listing” as an ASCII plain text file in compliance with 37 CFR 1.821 – 1.824. For applications filed on or after July 1, 2022: Submit a “Sequence…
Read MoreWhat are the requirements for submitting biological sequence listings in patent applications?
The requirements for submitting biological sequence listings in patent applications depend on the filing date of the application: For applications filed before July 1, 2022: A “Sequence Listing” must be submitted as an ASCII plain text file in compliance with 37 CFR 1.821-1.824. It can be submitted via the USPTO patent electronic filing system or…
Read MoreHow are biological sequences defined in patent applications?
The definition of biological sequences in patent applications depends on the filing date of the application: For applications filed before July 1, 2022: Biological sequences are defined in 37 CFR 1.821(a). For applications filed on or after July 1, 2022: Biological sequences are defined in 37 CFR 1.831(b). MPEP 608.05(c) states: “Applications disclosing nucleotide and/or…
Read More